CN1423131A - 糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 - Google Patents
糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 Download PDFInfo
- Publication number
- CN1423131A CN1423131A CN 02145561 CN02145561A CN1423131A CN 1423131 A CN1423131 A CN 1423131A CN 02145561 CN02145561 CN 02145561 CN 02145561 A CN02145561 A CN 02145561A CN 1423131 A CN1423131 A CN 1423131A
- Authority
- CN
- China
- Prior art keywords
- detection lug
- solid phase
- miniature
- phase detection
- miniature solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 45
- 238000001514 detection method Methods 0.000 title claims description 169
- 238000002360 preparation method Methods 0.000 title claims description 35
- 230000001363 autoimmune Effects 0.000 title claims description 29
- 239000002131 composite material Substances 0.000 title 1
- 239000007790 solid phase Substances 0.000 claims abstract description 79
- 238000006243 chemical reaction Methods 0.000 claims abstract description 52
- 238000002493 microarray Methods 0.000 claims abstract description 36
- 210000004153 islets of langerhan Anatomy 0.000 claims abstract description 28
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000011521 glass Substances 0.000 claims abstract description 15
- 102000004877 Insulin Human genes 0.000 claims abstract description 13
- 108090001061 Insulin Proteins 0.000 claims abstract description 13
- 238000000018 DNA microarray Methods 0.000 claims abstract description 5
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 25
- 210000002966 serum Anatomy 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 238000005070 sampling Methods 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 17
- 238000012360 testing method Methods 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 238000003908 quality control method Methods 0.000 claims description 16
- 230000036541 health Effects 0.000 claims description 13
- 229940125396 insulin Drugs 0.000 claims description 13
- 230000014759 maintenance of location Effects 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 9
- 239000012895 dilution Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 229920002643 polyglutamic acid Polymers 0.000 claims description 9
- 239000004793 Polystyrene Substances 0.000 claims description 7
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims description 7
- 239000006059 cover glass Substances 0.000 claims description 7
- 229920002223 polystyrene Polymers 0.000 claims description 7
- 241000594182 Sarcophaga sigma Species 0.000 claims description 6
- 238000000338 in vitro Methods 0.000 claims description 6
- 239000013642 negative control Substances 0.000 claims description 6
- 239000013641 positive control Substances 0.000 claims description 6
- 230000035945 sensitivity Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 210000004923 pancreatic tissue Anatomy 0.000 claims description 5
- 239000002356 single layer Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 210000004748 cultured cell Anatomy 0.000 claims description 4
- 230000004907 flux Effects 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 210000002718 aborted fetus Anatomy 0.000 claims description 3
- YAJCHEVQCOHZDC-QMMNLEPNSA-N actrapid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3N=CNC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@H](C)CC)[C@H](C)CC)[C@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C(N)=O)C1=CNC=N1 YAJCHEVQCOHZDC-QMMNLEPNSA-N 0.000 claims description 3
- 230000001464 adherent effect Effects 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- LEMUFSYUPGXXCM-JNEQYSBXSA-N caninsulin Chemical compound [Zn].C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3N=CN=C3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1C=NC=N1 LEMUFSYUPGXXCM-JNEQYSBXSA-N 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 238000011010 flushing procedure Methods 0.000 claims description 3
- 239000011888 foil Substances 0.000 claims description 3
- 230000000873 masking effect Effects 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 230000008521 reorganization Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 108010058683 Immobilized Proteins Proteins 0.000 claims description 2
- 238000003491 array Methods 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 claims description 2
- 229920002301 cellulose acetate Polymers 0.000 claims description 2
- 230000009194 climbing Effects 0.000 claims description 2
- 238000011207 functional examination Methods 0.000 claims description 2
- 201000002529 islet cell tumor Diseases 0.000 claims description 2
- 238000009533 lab test Methods 0.000 claims description 2
- 208000022102 pancreatic neuroendocrine neoplasm Diseases 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 230000001360 synchronised effect Effects 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 108091022930 Glutamate decarboxylase Proteins 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000002795 fluorescence method Methods 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 19
- 238000003745 diagnosis Methods 0.000 description 11
- 102100034091 Receptor-type tyrosine-protein phosphatase-like N Human genes 0.000 description 8
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 8
- 238000012880 independent component analysis Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 108010044226 Class 8 Receptor-Like Protein Tyrosine Phosphatases Proteins 0.000 description 3
- -1 GADA Proteins 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940127017 oral antidiabetic Drugs 0.000 description 1
- 239000003538 oral antidiabetic agent Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021455619A CN1176377C (zh) | 2002-12-30 | 2002-12-30 | 糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021455619A CN1176377C (zh) | 2002-12-30 | 2002-12-30 | 糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1423131A true CN1423131A (zh) | 2003-06-11 |
CN1176377C CN1176377C (zh) | 2004-11-17 |
Family
ID=4750933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021455619A Expired - Fee Related CN1176377C (zh) | 2002-12-30 | 2002-12-30 | 糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1176377C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100342027C (zh) * | 2005-09-22 | 2007-10-10 | 山东省医药生物技术研究中心 | 利用apes修饰玻片制备蛋白质、dna及脂类微阵列的方法 |
CN100378458C (zh) * | 2005-09-30 | 2008-04-02 | 中国科学院长春应用化学研究所 | 固相白色氨基反射层样品池制造方法 |
CN101210928B (zh) * | 2006-12-31 | 2012-07-25 | 陕西北美基因股份有限公司 | 用功能糖芯片及飞行质谱仪分析糖结合蛋白的方法 |
CN103018434A (zh) * | 2012-12-05 | 2013-04-03 | 北京鸿天志远科技有限公司 | 一种多指标检测装置及一种试剂盒,及其应用 |
CN103969234A (zh) * | 2014-04-17 | 2014-08-06 | 山东东兴汇智生物科技有限公司 | 可同时检测四种i型糖尿病自身免疫抗体的方法 |
CN104977419A (zh) * | 2014-04-01 | 2015-10-14 | 苏州浩欧博生物医药有限公司 | 一种自身免疫性抗原阳性血清的纯化制备方法 |
CN108620144A (zh) * | 2018-07-10 | 2018-10-09 | 南京宝沃生物科技有限公司 | 一种用于wb实验中的微流体芯片 |
WO2019169793A1 (zh) * | 2018-03-07 | 2019-09-12 | 深圳市伯劳特生物制品有限公司 | 一种组合物、芯片及其制备方法和包含有该芯片的检测装置 |
CN114034683A (zh) * | 2021-12-01 | 2022-02-11 | 吉林大学 | 一种快速诊断1型糖尿病的多重免疫芯片及其制备方法和应用 |
-
2002
- 2002-12-30 CN CNB021455619A patent/CN1176377C/zh not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100342027C (zh) * | 2005-09-22 | 2007-10-10 | 山东省医药生物技术研究中心 | 利用apes修饰玻片制备蛋白质、dna及脂类微阵列的方法 |
CN100378458C (zh) * | 2005-09-30 | 2008-04-02 | 中国科学院长春应用化学研究所 | 固相白色氨基反射层样品池制造方法 |
CN101210928B (zh) * | 2006-12-31 | 2012-07-25 | 陕西北美基因股份有限公司 | 用功能糖芯片及飞行质谱仪分析糖结合蛋白的方法 |
CN103018434A (zh) * | 2012-12-05 | 2013-04-03 | 北京鸿天志远科技有限公司 | 一种多指标检测装置及一种试剂盒,及其应用 |
CN104977419A (zh) * | 2014-04-01 | 2015-10-14 | 苏州浩欧博生物医药有限公司 | 一种自身免疫性抗原阳性血清的纯化制备方法 |
CN103969234A (zh) * | 2014-04-17 | 2014-08-06 | 山东东兴汇智生物科技有限公司 | 可同时检测四种i型糖尿病自身免疫抗体的方法 |
CN103969234B (zh) * | 2014-04-17 | 2017-02-15 | 山东东兴汇智生物科技有限公司 | 一种荧光素酶‑多抗原融合蛋白以及蛋白a琼脂糖‑融合蛋白‑抗体复合物 |
WO2019169793A1 (zh) * | 2018-03-07 | 2019-09-12 | 深圳市伯劳特生物制品有限公司 | 一种组合物、芯片及其制备方法和包含有该芯片的检测装置 |
CN108620144A (zh) * | 2018-07-10 | 2018-10-09 | 南京宝沃生物科技有限公司 | 一种用于wb实验中的微流体芯片 |
CN114034683A (zh) * | 2021-12-01 | 2022-02-11 | 吉林大学 | 一种快速诊断1型糖尿病的多重免疫芯片及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1176377C (zh) | 2004-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1173182C (zh) | 糖尿病自身免疫抗体检测蛋白芯片、其制备及检测方法 | |
JP2020030841A (ja) | 統合型の保健データ取得および分析システム | |
US8357497B2 (en) | Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets | |
CN1525168A (zh) | 早老性痴呆的检测方法 | |
CN1176377C (zh) | 糖尿病自身免疫抗体检测复合芯片及其制备、检测方法 | |
CN1362970A (zh) | 对雌激素受激亮氨酸氨基太酶的单克隆抗体 | |
CN1234118A (zh) | 涉及糖尿病和肥胖症的诊断及治疗的材料与方法 | |
CN104204811B (zh) | 胰腺β‑细胞紊乱中的可溶性MANF | |
Klein et al. | Further studies on the membrane immunofluorescence reaction of Burkitt lymphoma cells | |
CN113138272A (zh) | 一种检测泛素结合酶抗体的试剂盒及使用方法 | |
ES2421257T3 (es) | Método y aparato para el ensayo simultáneo de varios analitos con un control interno | |
CN107091925B (zh) | 一种检测牙周炎相关蛋白的试剂盒 | |
CN106872697B (zh) | 中华蜜蜂囊状幼虫病病毒免疫胶体金试纸条 | |
CN1439878A (zh) | 自身抗体检测组织芯片 | |
WO2015066035A1 (en) | Compositions and methods for evaluating metabolic syndrome and related diseases | |
CN110339363A (zh) | PKC酶抑制剂在制备改善和保护胰岛beta细胞功能药物中的用途 | |
CN1448724A (zh) | 1型糖尿病相关抗原抗体同时检测蛋白芯片 | |
CN1058099A (zh) | 一种体外检测人和动物中存在环状颗粒和恶性肿瘤的方法及探针 | |
CN1569884A (zh) | 黄芪甲苷的制法及在制备防治糖尿病肾病药物中的应用 | |
RU2737336C1 (ru) | Способ определения иммунологической реактивности организма животных | |
CN112048540B (zh) | 胰岛内源胰岛素分泌的检测方法及应用 | |
CN1221258C (zh) | 苄达赖氨酸在制备预防和治疗糖尿病肾病药物中的应用 | |
CN112067822B (zh) | 一种凝集素探针组合在基于尿蛋白糖型鉴别黑叶猴性别方面的应用 | |
RU2743363C1 (ru) | Способ тестирования иммунологической толерантности у животных | |
CN2826438Y (zh) | 肝炎与肝硬化的集成检测反应板和蛋白芯片试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANXI CHAOYING BIOLOGY SCIENCE CO., LTD. Free format text: FORMER OWNER: CHAOYING BIO-MEDICAL RESEARCH AND DEVELOPMENT CO LTD, SHAANXI Effective date: 20051125 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20051125 Address after: 710061 No. 29 South Changan Road, Shaanxi, Xi'an Patentee after: Shaanxi Chaoying Biotechnology Co., Ltd. Address before: 710061 No. 29 South Changan Road, Shaanxi, Xi'an Patentee before: Chaoying Bio-Medical Research and Development Co., Ltd., Shaanxi |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181102 Address after: 710065 room 109, Tuo Chuang building, 2 hi-tech five road, hi tech Zone, Xi'an, Shaanxi Patentee after: Xi'an Bestedit Biomedical Services Co., Ltd. Address before: 710061 No. 29 South Changan Road, Shaanxi, Xi'an Patentee before: Shaanxi Chaoying Biotechnology Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041117 Termination date: 20191230 |
|
CF01 | Termination of patent right due to non-payment of annual fee |